Literature DB >> 20394721

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

Germaine Hanquet1, Anne Perrocheau, Esther Kissling, Daniel Levy Bruhl, David Tarragó, James Stuart, Pawel Stefanoff, Sigrid Heuberger, Paula Kriz, Anne Vergison, Sabine C de Greeff, Andrew Amato-Gauci, Lucia Pastore Celentano.   

Abstract

In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance. We confirmed the heterogeneity of surveillance systems and case definitions across countries but identified elements common to all countries, such as the availability of serotyping and the surveillance of pneumococcal meningitis. PCV impact was monitored in 11/15 countries using it. We propose steps for the monitoring of incidence rates and serotype distribution at EU level, to assess the need to introduce PCV and monitor its impact once introduced. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20394721     DOI: 10.1016/j.vaccine.2010.03.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Impact of implementing French antibiotic guidelines for acute respiratory-tract infections in a paediatric emergency department, 2005-2009.

Authors:  F Angoulvant; D Skurnik; H Bellanger; H Abdoul; X Bellettre; L Morin; M Aptecar; G Galli-Gibertini; O Bourdon; C Doit; A Faye; J-C Mercier; R Cohen; C Alberti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-16       Impact factor: 3.267

2.  Simultaneous identification of 29 prevalent invasive pneumococcal serotypes or pairs of serotypes by hybridization-ligation PCR.

Authors:  Montserrat Ortega Doménech; David Tarragó Asensio
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

Review 3.  Paediatric pneumococcal disease in Central Europe.

Authors:  R Prymula; R Chlibek; I Ivaskeviciene; A Mangarov; Zs Mészner; P Perenovska; D Richter; N Salman; P Simurka; E Tamm; G Tešović; I Urbancikova; V Usonis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-11       Impact factor: 3.267

4.  Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.

Authors:  Juan Picazo; Jesus Ruiz-Contreras; Juan Casado-Flores; Sagrario Negreira; Maria-Jesus García-de-Miguel; Teresa Hernández-Sampelayo; Enrique Otheo; Cristina Méndez
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

5.  One year period of invasive pneumococcal disease in children from a tertiary care hospital in Turkey in the post-vaccine era.

Authors:  Gulnihan Ustundag; Eda Karadag-Oncel; Sebahat Sen-Tas; Ahu Kara-Aksay; Dilek Yilmaz-Ciftdogan; Nisel Yilmaz; Mehmet Ceyhan
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

6.  Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.

Authors:  Pilar Ciruela; Ana Martínez; Conchita Izquierdo; Sergi Hernández; Sonia Broner; Carmen Muñoz-Almagro; Àngela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

7.  Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Authors:  Adoración Navarro-Torné; Eva Agostina Montuori; Vasiliki Kossyvaki; Cristina Méndez
Journal:  Hum Vaccin Immunother       Date:  2021-06-09       Impact factor: 4.526

8.  The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation.

Authors:  Nina Katharina Stock; Marek Maly; Helena Sebestova; Hana Orlikova; Jana Kozakova; Pavla Krizova
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

Review 9.  A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009-2016).

Authors:  Marta Moreira; Olga Castro; Melissa Palmieri; Sofia Efklidou; Stefano Castagna; Bernard Hoet
Journal:  Hum Vaccin Immunother       Date:  2016-12-20       Impact factor: 3.452

10.  Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.

Authors:  Alessandro Cassini; Edoardo Colzani; Alessandro Pini; Marie-Josee J Mangen; Dietrich Plass; Scott A McDonald; Guido Maringhini; Alies van Lier; Juanita A Haagsma; Arie H Havelaar; Piotr Kramarz; Mirjam E Kretzschmar
Journal:  Euro Surveill       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.